AI has entered the public sphere, catalyzed by the recent wave of generative AI. But there is much more that constitutes AI research than just language models and image generation. In this keynote conversation, Daphne Koller explains the potentials of generative AI in drug discovery.

Speaker:
Daphne Koller
CEO and Founder, insitro; Adjunct Professor of Computer Science, Stanford University